Form 4: Genelux Corp Director James L. Tyree Sells Shares Under 10b5-1 Trading Plan

Director James L. Tyree of Genelux Corp sold 1,730 shares of common stock at an average price of $2.6005, pursuant to a pre-arranged Rule 10b5-1 trading plan.

Summary

• On September 11, 2024, James L. Tyree, a director of Genelux Corporation, sold 1,730 shares of common stock.
• The transaction was executed at a weighted average price of $2.6005 per share, with prices ranging from $2.50 to $2.68.
• The sale was conducted under a Rule 10b5-1 trading plan adopted on December 13, 2023.
• Following the transaction, Tyree directly owns 47,521 shares of Genelux Corp.
• The transaction was reported on a Form 4 filing with the SEC on September 12, 2024.

Sentiment

Score: 5

Explanation: The document is a standard SEC filing reporting a share sale by a company director under a pre-arranged trading plan. It doesn't inherently convey positive or negative sentiment.

Industry Context

Sales by company insiders are a common occurrence and are often pre-planned to avoid accusations of insider trading. Rule 10b5-1 plans allow insiders to sell shares at predetermined times and prices.

Stakeholder Impact

• The sale of shares by a director could have a minor impact on shareholder confidence, but the pre-planned nature of the sale mitigates this concern.

Key Dates